Dasta, Joseph F., M.Sc., R.Ph.

512-514-1821
jdasta@mail.utexas.edu

Professor Dasta received his B.Sc. in Pharmacy in 1974 from West Virginia University School of Pharmacy and M.Sc. and residency in Hospital Pharmacy from Ohio State University (OSU) in 1976. Professor Dasta was the 2008 recipient of the Jack L. Beal Post-baccalaureate Alumni Award from Ohio State. He began his academic career in 1976 at OSU and developed one of the first practice sites and post-doctoral training programs in critical care pharmacy. He has trained 11 residents and nine fellows who have become prominent practitioners, researchers, and leaders in the profession and in pharmaceutical industry. The accomplishments of his first resident, Judi Jacobi, Pharm.D., are particularly noteworthy. She will become the first pharmacist president of Society of Critical Care Medicine (SCCM) in 2010.

Professor Dasta was one of the first pharmacist members of SCCM and helped establish the role of the pharmacist in this multidisciplinary society. There are currently 1,000 pharmacist members. SCCM has honored him by creating the Joseph F. Dasta Critical Care Pharmacy Outcomes Research Grant in 2000. Professor Dasta was recently elected to a three-year term on council, the governing body of SCCM. He is a fellow of the American College of Clinical Pharmacy and the American College of Critical Care Medicine. He serves on the editorial board of Critical Care Medicine and Annals of Pharmacotherapy. Professor Dasta has more than 200 peer-reviewed publications, abstracts, brief communications, and book chapters. He has given more than 250 lectures on various topics related to critical care and health outcomes.

His research has focused on clinical response, health economics and patient safety of acute care pharmaceuticals. Specific areas of interest include sedation, sepsis, acute renal failure and acute heart failure, anemia in the ICU, hyponatremia, and hypertensive emergencies.

Role as a Consultant

Professor Dasta retired from OSU in June 2007 after 31 years. He currently resides in Austin Texas and is a healthcare consultant to pharmaceutical and device companies, and Seton Medical Center Williamson-ICU. He holds appointments as adjunct professor at The University of Texas at Austin and as professor emeritus from Ohio State University. He has been a consultant and member of the speaker's bureau of several pharmaceutical and device manufacturers including Abbott Point of Care, Brahms-USA, Cadence Pharmaceuticals, Canyon Pharmaceuticals, Hospira, Keimar, The Medicines Company, and VISICU. Professor Dasta has provided evaluation and insight into investigational and marketed drugs and devices, formulary decisions, protocol development, and pharmacoeconomic perspectives; including cost-effectiveness studies. He has also been involved with the area of business development for the pharmaceutical industry.

More information about Mr. Dasta
> Publications